The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis

BACKGROUND: With the emergence of coronavirus disease of 2019 (COVID-19), several blood biomarkers have been identified, including the endothelial biomarker syndecan-1, a surface proteoglycan. In the current systematic review and meta-analysis, we aimed to assess the diagnostic and prognostic role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghondaghsaz, Elina, Khalaji, Amirmohammad, Norouzi, Mitra, Fraser, Douglas D., Alilou, Sanam, Behnoush, Amir Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401738/
https://www.ncbi.nlm.nih.gov/pubmed/37542221
http://dx.doi.org/10.1186/s12879-023-08473-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401738/
https://www.ncbi.nlm.nih.gov/pubmed/37542221
http://dx.doi.org/10.1186/s12879-023-08473-9

Ejemplares similares